For personal use only
Four Big Trials at ASCO Yield Practice-Changing Data
Response rates Overall response rate and depth of response according to... | Download Scientific Diagram
Analysis of duration of response in oncology trials. | Semantic Scholar
Efficacy endpoints in Oncology
Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy - ScienceDirect
Simplifying the Derivation of Best Overall Response per RECIST 1.1 and iRECIST in Solid Tumor Clinical Studies
Abbreviations: CR, complete response; ORR, objective response rate; PR,... | Download Scientific Diagram
Physical exercise during neoadjuvant chemotherapy for breast cancer as a mean to increase pathological complete response rates: Trial protocol of the randomized Neo-ACT trial | PLOS ONE
Objective response rate is a possible surrogate endpoint for survival in patients with advanced, recurrent ovarian cancer - ScienceDirect
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials | Journal for ImmunoTherapy of Cancer | Full Text
Objective response rate assessment in oncology: Current situation and future expectations
Study Results | ZYNLONTA® (loncastuximab tesirine-lpyl) Patient Site
Use of Clinical Trials in Expanding Treatment for Ovarian Cancer - ppt download
Clinical Trial Endpoints for Oncology Studies
Relationship Between Progression‐Free Survival, Objective Response Rate, and Overall Survival in Clinical Trials of PD‐1/PD‐L1 Immune Checkpoint Blockade: A Meta‐Analysis - Ye - 2020 - Clinical Pharmacology & Therapeutics - Wiley Online
Dara-KRd and tandem ASCT for patients with high-risk NDMM: Results of the IFM-2018-04 trial
Frontiers | Investigation of the efficacy and safety of cryoablation and intra-arterial PD-1 inhibitor in patients with advanced disease not responding to checkpoint inhibitors: An exploratory study
Starting with higher-dose prednisone boosts 1-year renal response in lupus nephritis
Iovance Biotherapeutics: The Frontier Of Novel Cancer Treatment (NASDAQ:IOVA) | Seeking Alpha
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials | Journal for ImmunoTherapy of Cancer | Full Text
The overall response rate | Download Table
KAZIA PRESENTS FURTHER PAXALISIB AND CANTRIXIL DATA AT AACR, REINFORCING POSITIVE EFFICACY SIGNALS FOR BOTH DRUGS
Response Rate Definition | The Online Advertising Guide
Clinical Outcomes and Adverse Events after First-Line Treatment in Metastatic Renal Cell Carcinoma: A Systematic Review and Netw
